New Zealand vs Singapore: Expected share of deaths from non-communicable diseases
New Zealand
10.3%
in 2021
Singapore
10.3%
in 2021
New Zealand rank
157th
Singapore rank
157th
Expected share of deaths from non-communicable diseases over time
- New Zealand
- Singapore
How they compare
New Zealand currently reports 10.3% against 10.3% in Singapore, a difference of 0.0%.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Singapore ahead.
New Zealand ranks 157th and Singapore ranks 157th of 185 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | New Zealand | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.9% | 13.7% | 0.2% | New Zealand |
| 2010s | 11.1% | 9.9% | 1.2% | New Zealand |
| 2020s | 10.2% | 9.6% | 0.5% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected share of deaths from non-communicable diseases, New Zealand or Singapore?
- New Zealand, at 10.3% against 10.3% in Singapore as of 2021.
- What is the difference in expected share of deaths from non-communicable diseases between New Zealand and Singapore?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Singapore?
- 22 years are reported by both, from 2000 to 2021.
- How do New Zealand and Singapore rank globally for expected share of deaths from non-communicable diseases?
- New Zealand ranks 157th and Singapore ranks 157th of 185 countries.
- Where does this data come from?
- World Health Organization (WHO), Global Health Observatory, via World Bank (2026) – processed by Our World in Data, published as Expected share of deaths from non-communicable diseases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.